Market overview
The global amniotic membrane market is worth USD 2.2 bn in 2026 and is forecast to reach USD 4.9 bn by 2036, growing at a 8.5% CAGR. United States is the largest country market and Dehydrated grafts is the largest by product form segment.
| Scope | Processed human amniotic membrane grafts and products used in wound care, ophthalmic surgery, orthopaedics and dental procedures, sold as sheets, powders, injectables and cryopreserved or dehydrated grafts. |
|---|---|
| Industry | Healthcare |
| Value 2025 | USD 2.0 bn |
| Value 2026 | USD 2.2 bn |
| Value 2036 | USD 4.9 bn |
| CAGR 2026-2036 | 8.5% |
| Volume 2026 | 1,735 thousand grafts |
| Volume 2036 | 3,733 thousand grafts |
| Average price 2026 | USD 1,256 per graft |
| Report price | Starts from USD 1,999 |
| Published | November 2026 |
Request a free sample of this report
Amniotic Membrane market size and forecast, 2026-2036
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Year | Market value |
|---|---|
| 2026 | USD 2.2 bn |
| 2027 | USD 2.4 bn |
| 2028 | USD 2.6 bn |
| 2029 | USD 2.8 bn |
| 2030 | USD 3.0 bn |
| 2031 | USD 3.3 bn |
| 2032 | USD 3.6 bn |
| 2033 | USD 3.9 bn |
| 2034 | USD 4.2 bn |
| 2035 | USD 4.5 bn |
| 2036 | USD 4.9 bn |
Amniotic Membrane market segmentation
By product form
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Dehydrated grafts | 46.0% | 42.6% | USD 1.0 bn | 7.7% |
| Cryopreserved grafts | 24.0% | 23.7% | USD 523 mn | 8.4% |
| Fluid and injectable products | 18.0% | 22.3% | USD 392 mn | 10.9% |
| Powders and other forms | 12.0% | 11.3% | USD 262 mn | 7.9% |
By application
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Chronic wound care | 52.0% | 51.6% | USD 1.1 bn | 8.4% |
| Ophthalmology | 20.0% | 20.8% | USD 436 mn | 8.9% |
| Surgical and orthopaedic | 16.0% | 16.3% | USD 349 mn | 8.7% |
| Dental and other | 12.0% | 11.4% | USD 262 mn | 7.9% |
By tissue layer
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Amnion | 46.0% | 44.0% | USD 1.0 bn | 8.0% |
| Amnion-chorion | 28.0% | 29.0% | USD 610 mn | 8.9% |
| Umbilical cord and Wharton's jelly | 26.0% | 27.0% | USD 567 mn | 8.9% |
By end user
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Hospitals | 42.0% | 40.0% | USD 916 mn | 8.0% |
| Ambulatory surgery centres | 22.0% | 23.0% | USD 480 mn | 9.0% |
| Wound care clinics | 24.0% | 25.0% | USD 523 mn | 8.9% |
| Eye clinics | 12.0% | 12.0% | USD 262 mn | 8.5% |
By processing method
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Terminally sterilised | 48.0% | 47.0% | USD 1.0 bn | 8.3% |
| Aseptically processed | 38.0% | 38.0% | USD 828 mn | 8.5% |
| Lyophilised and powdered | 14.0% | 15.0% | USD 305 mn | 9.2% |
Top 25 countries for amniotic membrane by revenue
Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 94.5% of 2026 revenue and the 25 countries below together hold 98.4%.
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| # | Country | Value 2026 | Share 2026 | Value 2036 | CAGR 2026-36 |
|---|---|---|---|---|---|
| 1 | United States | USD 1.5 bn | 68.0% | USD 3.2 bn | 8.0% |
| 2 | Germany | USD 98 mn | 4.5% | USD 232 mn | 9.0% |
| 3 | China | USD 87 mn | 4.0% | USD 271 mn | 12.0% |
| 4 | Japan | USD 76 mn | 3.5% | USD 168 mn | 8.2% |
| 5 | United Kingdom | USD 76 mn | 3.5% | USD 173 mn | 8.5% |
| 6 | France | USD 65 mn | 3.0% | USD 148 mn | 8.5% |
| 7 | India | USD 54 mn | 2.5% | USD 168 mn | 11.9% |
| 8 | Italy | USD 44 mn | 2.0% | USD 99 mn | 8.5% |
| 9 | Canada | USD 44 mn | 2.0% | USD 99 mn | 8.5% |
| 10 | Brazil | USD 33 mn | 1.5% | USD 84 mn | 9.9% |
| 11 | Spain | USD 9.4 mn | 0.4% | USD 20 mn | 7.7% |
| 12 | Australia | USD 9.4 mn | 0.4% | USD 20 mn | 7.7% |
| 13 | South Korea | USD 8.5 mn | 0.4% | USD 20 mn | 9.0% |
| 14 | Netherlands | USD 6.8 mn | 0.3% | USD 14 mn | 7.8% |
| 15 | Mexico | USD 6.8 mn | 0.3% | USD 16 mn | 9.2% |
| 16 | Switzerland | USD 5.9 mn | 0.3% | USD 12 mn | 7.7% |
| 17 | Turkey | USD 5.0 mn | 0.2% | USD 13 mn | 10.2% |
| 18 | Saudi Arabia | USD 5.0 mn | 0.2% | USD 13 mn | 10.2% |
| 19 | Argentina | USD 4.1 mn | 0.2% | USD 8.9 mn | 7.9% |
| 20 | Poland | USD 4.1 mn | 0.2% | USD 9.9 mn | 9.1% |
| 21 | Israel | USD 4.1 mn | 0.2% | USD 9.9 mn | 9.1% |
| 22 | Russia | USD 4.1 mn | 0.2% | USD 8.9 mn | 7.9% |
| 23 | Belgium | USD 4.1 mn | 0.2% | USD 8.9 mn | 7.9% |
| 24 | Sweden | USD 4.1 mn | 0.2% | USD 8.9 mn | 7.9% |
| 25 | Singapore | USD 3.5 mn | 0.2% | USD 7.9 mn | 8.5% |
| Rest of world | USD 35 mn | 1.6% | USD 84 mn | 9.2% |
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
Competitive landscape
Group 1: Global leaders
- MiMedx Group
- Organogenesis
- Smith & Nephew
- TissueTech
- Celularity
- AlloSource
- MTF Biologics
Group 2: Regional and specialist players
- Integra LifeSciences
- Bioventus
- Katena Products
- Surgenex
- StimLabs
- BioStem Technologies
- Amnio Technology
- Applied Biologics
- Tides Medical
- Vivex Biomedical
Group 3: Emerging and niche players
- BioLab Sciences
- LifeNet Health
- Sanara MedTech
- Tissue Regenix
- Elutia
Research methodology
Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the amniotic membrane market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.
The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 8.5% is calculated from the resulting values.
The market is divided by product form, by application, by tissue layer, by end user, by processing method. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.
Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.
Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.
Frequently asked questions
How big is the amniotic membrane market?
The global amniotic membrane market is estimated at USD 2.0 bn in 2025 and USD 2.2 bn in 2026.
How fast will the amniotic membrane market grow?
It is forecast to reach USD 4.9 bn by 2036, a compound annual growth rate of 8.5% from 2026, an increase of USD 2.7 bn.
Which country is the largest market for amniotic membrane?
United States is the largest market by revenue at USD 1.5 bn in 2026, 68.0% of the global total. The three largest countries together hold 76.5%.
Which country is growing fastest?
Among the ten largest markets, China is growing fastest at 12.0% a year from 2026 to 2036.
Which amniotic membrane segment is largest?
In the by product form split, Dehydrated grafts is the largest segment with 46.0% of 2026 revenue.
Who are the leading amniotic membrane companies?
Global leaders include MiMedx Group, Organogenesis, Smith & Nephew, TissueTech.
Need the full report?
Request a sample to see the structure, tables and country detail.
Request a free sampleRelated markets in Healthcare
- New Approach Methodologies Nonclinical TestingUSD 2.2 bn · 13.0% CAGR
- Point-of-Care Respiratory Diagnostic PanelsUSD 2.2 bn · 6.5% CAGR
- Medical CannulaUSD 2.3 bn · 5.3% CAGR
- Dental SterilizationUSD 2.0 bn · 6.0% CAGR
- Tangential Flow FiltrationUSD 2.5 bn · 9.0% CAGR
- Cardiovascular Drug DiscoveryUSD 2.6 bn · 7.5% CAGR
- Healthcare APIUSD 1.8 bn · 16.0% CAGR
- Chromatography ResinUSD 2.6 bn · 9.8% CAGR